Authors: ROTHENBERG ML MOORE MJ CRIPPS MC ANDERSEN JS PORTENOY RK BURRIS HA GREEN MR TARASSOFF PG BROWN TD CASPER ES STORNIOLO AM VONHOFF DD ALBERTS DS WOLFF R KELSEN DP KOCHA W HALLER DG MODIANOREVAH M MOORE M OKEN MM SCHILSKY RL SHAH A

Citation: Ml. Rothenberg et al., A PHASE-II TRIAL OF GEMCITABINE IN PATIENTS WITH 5-FU-REFRACTORY PANCREAS CANCER, Annals of oncology, 7(4), 1996, pp. 347-353

Authors: OROURKE TJ BROWN TD HAVLIN K KUHN JG CRAIG JB BURRIS HA SATTERLEE WG TARASSOFF PG VONHOFF DD

Citation: Tj. Orourke et al., PHASE-I CLINICAL-TRIAL OF GEMCITABINE GIVEN AS AN INTRAVENOUS BOLUS ON 5 CONSECUTIVE DAYS, European journal of cancer, 30A(3), 1994, pp. 417-419

Authors: CASPER ES GREEN MR KELSEN DP HEELAN RT BROWN TD FLOMBAUM CD TROCHANOWSKI B TARASSOFF PG

Citation: Es. Casper et al., PHASE-II TRIAL OF GEMCITABINE (2,2'-DIFLUORODEOXYCYTIDINE) IN PATIENTS WITH ADENOCARCINOMA OF THE PANCREAS, Investigational new drugs, 12(1), 1994, pp. 29-34

Authors: CHRISTMAN K KELSEN D SALTZ L TARASSOFF PG

Citation: K. Christman et al., PHASE-II TRIAL OF GEMCITABINE IN PATIENTS WITH ADVANCED GASTRIC-CANCER, Cancer, 73(1), 1994, pp. 5-7